The rating affirmation is based on a number of factors, including KDMC’s rebounding profitability.
The outlook is negative, reflecting KDMC’s weakened liquidity and declining inpatient and outpatient utilization.
More articles on healthcare finance:
6 states where most hospital-affiliated physicians accept pharma, device payments
US hospitals see weaker volumes of less acute patients in Q1
CMS considers modifications to ambitious Medicare Part B payment experiment
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
